Expand Labeling for Testosterone Replacement Therapy, FDA Panel Says

(MedPage Today) — Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance.
Like previous FDA expert panels, the group was convened by Commissioner…